Cormorant Asset Management »

Helix Acquisition Corp Ii Cl A shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Helix Acquisition Corp Ii Cl A (HLXB) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Helix Acquisition Corp Ii Cl A

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp Ii Cl A held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp Ii Cl A by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $30M 2.9M 10.22
2024-03-31 $30M 2.9M 10.40

More positions owned by Cormorant Asset Management

Moonlake Immunotherapeutics Class A Ord (MLTX)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Arcellx Common Stock (ACLX)
Vaxcyte (PCVX)
Longboard Pharmaceuticals In (LBPH)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Merus N V (MRUS)
Bridgebio Pharma (BBIO)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Janux Therapeutics (JANX)
Axsome Therapeutics (AXSM)

View all positions for Cormorant Asset Management

Top funds holding Helix Acquisition Corp Ii Cl A

Cormorant Asset Management
BlackRock
Adage Capital Partners GP
Citadel Advisors
T. Rowe Price Associates
Millennium Management
OZ Management
Farallon Capital Management
Dr. Jeffrey R. Jay, M.D.
Silverarc Capital Management
Perceptive Advisors
Commodore Capital
Soros Fund Management
ADAR1 Capital Management
T. Rowe Price Investment Management

View all funds holding Helix Acquisition Corp Ii Cl A